Related references
Note: Only part of the references are listed.Surgery versus stereotactic radiosurgery for the treatment of multiple meningiomas in neurofibromatosis type 2: illustrative case and systematic review
Thien Nguyen et al.
NEUROSURGICAL REVIEW (2019)
Growth prediction in asymptomatic meningiomas: the utility of the AIMSS score
Ferran Brugada-Bellsola et al.
ACTA NEUROCHIRURGICA (2019)
Genetic Severity Score predicts clinical phenotype in NF2
Dorothy Halliday et al.
JOURNAL OF MEDICAL GENETICS (2017)
A novel weighted scoring system for estimating the risk of rapid growth in untreated intracranial meningiomas
Eun Jung Lee et al.
JOURNAL OF NEUROSURGERY (2017)
Growth Dynamics of Intracranial Tumors in Patients with Neurofibromatosis Type 2
Anna C. Lawson McLean et al.
WORLD NEUROSURGERY (2017)
Volumetric growth rates of meningioma and its correlation with histological diagnosis and clinical outcome: a systematic review
Daniel M. Fountain et al.
ACTA NEUROCHIRURGICA (2017)
Gamma Knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series
Brandon Birckhead et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2
Ann Liu et al.
JOURNAL OF NEUROSURGERY (2015)
3D Volumetric Measurement of Neurofibromatosis Type 2-Associated Meningiomas: Association Between Tumor Location and Growth Rate
Stefanie Evers et al.
WORLD NEUROSURGERY (2015)
Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2
Rosalie E. Ferner et al.
JOURNAL OF NEUROLOGY (2014)
Intracranial meningiomas and neurofibromatosis type 2
Rabih Aboukais et al.
ACTA NEUROCHIRURGICA (2013)
Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies
Naoya Hashimoto et al.
JOURNAL OF NEUROSURGERY (2012)
Long-term natural history of neurofibromatosis Type 2-associated intracranial tumors Clinical article
Michael S. Dirks et al.
JOURNAL OF NEUROSURGERY (2012)
Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features
Stphane Goutagny et al.
NEURO-ONCOLOGY (2012)
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2
Jaishri O. Blakeley et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2011)
Birth Incidence and Prevalence of Tumor-Prone Syndromes: Estimates From a UK Family Genetic Register Service
D. G. Evans et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2010)
Meningiomas and neurofibromatosis
Stephane Goutagny et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
CLINICAL EXPERIENCE WITH RADIATION THERAPY IN THE MANAGEMENT OF NEUROFIBROMATOSIS-ASSOCIATED CENTRAL NERVOUS SYSTEM TUMORS
Stacy Wentworth et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Neurofibromatosis type 2
Ashok R. Asthagiri et al.
LANCET (2009)
Neurofibromatosis type 2 (NF2): A clinical and molecular review
D. Gareth R. Evans
ORPHANET JOURNAL OF RARE DISEASES (2009)
Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2006)
Predictors of the risk of mortality in neurofibromatosis 2
ME Baser et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: A clinicopathologic study of 53 cases
A Perry et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Neurofibromatosis type 2
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2000)
Share Paper
